ArticleBioinformatics advances2026
SNP-based prediction of schizophrenia using machine learning.
Article in Bioinformatics advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Motivation: Schizophrenia is a complex psychiatric disorder characterized by the deterioration of intellectual processes and emotional responses, affecting ∼0.32% of the global population. The study of single nucleotide polymorphisms (SNPs) associated with schizophrenia is crucial to identifying pathogenic genetic variants and understanding the genetic architecture of this complex disorder. This study aims to demonstrate the feasibility of predicting schizophrenia using an individual's SNP profile. Results: We used genome-wide association (GWA) schizophrenia data from a case-control study across European-American (EA) and African-American (AA) populations, consisting of 4693 participants (46.1% diagnosed with schizophrenia). Machine learning techniques were employed to construct SNP-based predictive models specific to ethnicity-gender groups (EA-F, EA-M, AA-F, and AA-M) where "F" and "M" identify female and male populations, respectively. Feature selection and association analysis were utilized to rank and detect significantly associated SNPs. Model selection was based on stratified five-fold cross-validation. Our EA-F-, EA-M-, AA-F-, and AA-M-specific models achieved classification accuracies (AUC, sensitivity, specificity) of 75.1% (69.2%, 95.4%, 34.2%), 65.4% (74.3%, 73.6%, 58.6%), 68.6% (69.5%, 85.6%, 41.1%), and 73.9% (74.0%, 39.7%, 93.3%), respectively, in independent test sets from the same ethnicity-gender population. The high sensitivity (>70%) of AA-F, EA-F, and EA-M models can make them auxiliary clinical tools to assess the risk of developing schizophrenia disorder in AA-F, EA-F, and EA-M populations. Availability and implementation: The R and Python codes, along with the dataset used in this study are available at https://github.com/Zam-gif/Prediction-Models-of-Schizophrenia/tree/main.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.